FEATURED
Concerns over safety of Alzheimer’s drug after death of patient
NEW YORK: Concerns about safety risks of the controversial new Alzheimer’s drug Aduhelm have intensified read more
NEW YORK: Concerns about safety risks of the controversial new Alzheimer’s drug Aduhelm have intensified read more